| 수집원 | 발생값 ↑ | 관측 가능 시각 | 법인 | 회사명 | 사업연도 | 기간 | 연결구분 | 재무제표 | 계정명 | 표준 지표 | 금액 | 기준일 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 자본금 | capital_stock | 8761억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 부채총계 | total_liabilities | 64.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 29.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 유동부채 | current_liabilities | 35조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 자산총계 | total_assets | 101.9조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 비유동자산 | non_current_assets | 64.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | SK이노베이션 | SK이노베이션 | 2,026 | H1 | CFS | BS | 유동자산 | current_assets | 37.8조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | 4559.2억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | IS | 당기순이익(손실) | net_income | 4567.8억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | IS | 법인세차감전 순이익 | pretax_income | 6215.4억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | IS | 영업이익 | operating_income | 5984.8억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | IS | 매출액 | revenue | 1.3조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 자본총계 | total_equity | 8.3조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 이익잉여금 | retained_earnings | 5.9조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 자본금 | capital_stock | 1157.2억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 부채총계 | total_liabilities | 3.8조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 비유동부채 | non_current_liabilities | 1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 유동부채 | current_liabilities | 2.8조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 자산총계 | total_assets | 12.2조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 비유동자산 | non_current_assets | 7.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 삼성바이오로직스 | 삼성바이오로직스 | 2,026 | H1 | OFS | BS | 유동자산 | current_assets | 5.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 16.7조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | BS | 자본총계 | total_equity | 48.8조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | IS | 영업이익 | operating_income | 5995.8억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | IS | 법인세차감전 순이익 | pretax_income | 4293억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | IS | 당기순이익(손실) | net_income | 667.8억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | CFS | IS | 총포괄손익 | comprehensive_income | 8046.9억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 유동자산 | current_assets | 11조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 비유동자산 | non_current_assets | 22.9조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 자산총계 | total_assets | 34조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 유동부채 | current_liabilities | 7조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 비유동부채 | non_current_liabilities | 4.3조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-15 00:17:18 | LG | LG | 2,026 | H1 | OFS | BS | 자본총계 | total_equity | 10.3조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 부채총계 | total_liabilities | 11.4조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 자본금 | capital_stock | 3914억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 이익잉여금 | retained_earnings | 19.2조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | BS | 자본총계 | total_equity | 22.5조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | IS | 매출액 | revenue | 5.2조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | IS | 영업이익 | operating_income | 4318.5억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | IS | 법인세차감전 순이익 | pretax_income | 7417억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | IS | 당기순이익(손실) | net_income | 6014.7억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | LG화학 | LG화학 | 2,026 | H1 | OFS | IS | 총포괄손익 | comprehensive_income | 5001.5억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 유동자산 | current_assets | 6.9조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 비유동자산 | non_current_assets | 16.7조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 자산총계 | total_assets | 23.7조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 유동부채 | current_liabilities | 5.1조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 비유동부채 | non_current_liabilities | 5413.2억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 부채총계 | total_liabilities | 5.6조원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 자본금 | capital_stock | 2505.5억원 | 2026-06-30 |
| dart-financials | 2026-08-14 | 2026-08-16 00:17:16 | 셀트리온 | 셀트리온 | 2,026 | H1 | CFS | BS | 이익잉여금 | retained_earnings | 3.2조원 | 2026-06-30 |